Search

everythinglearnresearchcommunity

for

Search:↓

A new method effectively predicts estrogen-related health effects for early screening.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Serial trichoscopy is more reliable than the modified hair pull test for tracking alopecia areata.

About half of Taiwanese dermatologists use dermoscopy, mainly to improve diagnosis and detect cancer early, but cost and lack of training limit its wider use.

Trichotillometry can measure hair plucking force, aiding alopecia treatment evaluation.

TrichoScan accurately measures hair growth and showed improved hair counts and thickness after finasteride treatment.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Surgeons' testosterone levels significantly increase during major head and neck cancer surgeries.

EGFR inhibitors often cause dry, brittle hair and eyebrow/eyelash changes.

FDG PET/CT can improve cancer treatment plans in dogs.

Reconstructed skin models are useful for studying how skin processes certain chemicals.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

The conclusion is that a safe donor area for hair transplants varies and should be chosen based on individual factors like race, future hair loss, family history, and specific thinning patterns.

The TT/DHT ratio may help identify PCOS patients with severe metabolic issues.

A reliable severity score for female pattern hair loss was developed and validated.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

More biopsy cores and MRI before biopsy can improve prostate cancer detection.

The tool accurately tracks eyebrow hair loss in chemotherapy patients.

The modified Sinclair scale effectively measures hair loss severity in men.

Sporadic trichoblastic neoplasms generally don't recur or spread, with one case showing a specific genetic fusion.

A comprehensive scoring system for alopecia areata severity is needed.

ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.